SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 20th, 2018 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledJune 20th, 2018 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 14, 2018, by and between PROPANC BIOPHARMA, INC, a Delaware corporation, with headquarters located at 302, 6 Butler Street, Camberwell, VIC 3124 Australia (the “Company”), and EAGLE EQUITIES, LLC, with its address at 91 Shelton Ave, Suite 107, New Haven, CT 06511 (the “Buyer”).